Ambryon Biosciences

Streptococcus pyogenes Cas9 (SpCas9)

RNA-guided DNA endonuclease from Streptococcus pyogenes that cleaves double-stranded DNA at sites specified by a 20-nucleotide guide sequence, requiring an NGG PAM immediately 3' of the target. The most widely used nuclease for mammalian genome editing.

OriginStreptococcus pyogenes type II CRISPR-Cas system
Cut TypeBlunt
Pam SequenceNGG

Characteristics

Cleaves both strands of target DNA three base pairs upstream of the PAM, producing a blunt double-strand break; the HNH domain cuts the strand complementary to the guide and the RuvC-like domain cuts the noncomplementary strand. Efficient cleavage requires at least 13 contiguous base pairs of guide-target match immediately adjacent to the PAM, while mismatches further from the PAM are tolerated. In vitro cleavage proceeds at 0.3-1 min⁻¹ under single-turnover conditions, comparable to restriction endonucleases. Inactivating either catalytic domain - D10A in RuvC or H840A in HNH - converts the enzyme into a nickase that cuts only one strand.

Applications

Knockout and knock-in generation in mammalian cell lines, multiplexed editing with several guide RNAs delivered together, and pooled genetic screening with lentiviral guide libraries. Constitutive-Cas9 mouse lines support in vivo editing by guide delivery alone. Delivery to mouse brain has been achieved with dual-AAV split constructs.

Limitations

The 4.1 kb coding sequence leaves little room for a promoter and polyA within the single-AAV limit, so in vivo delivery generally requires dual-AAV split systems or a smaller ortholog such as SaCas9. The NGG PAM requirement restricts which sites can be targeted. Cleavage occurs at off-target sites with PAM-distal mismatches; the high-fidelity variants SpCas9-HF1 and eSpCas9 reduce this.

Sequence4,104 bp

Sign in to view the full sequence.

Sign in

References

  1. 1.Kleinstiver et al. (2016). High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature — Kleinstiver 2016 SpCas9-HF1
  2. 2.Slaymaker et al. (2016). Rationally engineered Cas9 nucleases with improved specificity. Science — Slaymaker 2016 eSpCas9
  3. 3.Ran et al. (2015). In vivo genome editing using Staphylococcus aureus Cas9. Nature — Ran 2015 SaCas9
  4. 4.Swiech et al. (2015). In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9. Nat Biotechnol — Swiech 2015 Dual AAV
  5. 5.Gilbert et al. (2014). Genome-scale CRISPR-mediated control of gene repression and activation. Cell — Gilbert 2014 CRISPR Screen
  6. 6.Platt et al. (2014). CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell — Platt 2014 Cas9 Mice
  7. 7.Cong et al. (2013). Multiplex genome engineering using CRISPR/Cas systems. Science — Cong 2013 SpCas9
  8. 8.Mali et al. (2013). CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol — Mali 2013 Cas9 Nickase
  9. 9.Jinek et al. (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science — Jinek 2012 SpCas9

Identifiers & revision